SOC 2 for Clinical Trial Technology: Why It Matters and What to Look For
What SOC 2 Type II certification means for EDC platforms, how the Trust Service Criteria apply to clinical trial data, and how to evaluate vendor security posture.
What Is SOC 2?
SOC 2 (System and Organization Controls 2) is an auditing standard developed by the American Institute of Certified Public Accountants (AICPA). It evaluates whether a service organisation’s controls are properly designed and operating effectively to protect customer data.
Unlike ISO 27001, which certifies a management system, SOC 2 evaluates actual operating effectiveness over a period of time. A SOC 2 Type II report covers a minimum of 6 months of continuous evidence — auditors test not just whether controls exist, but whether they worked consistently throughout the period.
For clinical trial technology, SOC 2 is becoming a baseline requirement. Sponsors and CROs increasingly require SOC 2 Type II reports from their technology vendors before trusting them with trial data.
The Five Trust Service Criteria
SOC 2 is built on five Trust Service Criteria. Each maps directly to clinical trial data requirements.
┌─────────────────────────────────────────────────────────┐
│ SOC 2 Trust Service Criteria │
├─────────────────────────────────────────────────────────┤
│ │
│ ┌──────────────┐ Security is MANDATORY. │
│ │ SECURITY │ The other four are optional │
│ │ (Common │ but strongly recommended │
│ │ Criteria) │ for clinical trial platforms. │
│ └──────┬───────┘ │
│ │ │
│ ┌──────▼───────┐ ┌──────────────┐ ┌──────────────┐ │
│ │ AVAILABILITY │ │ PROCESSING │ │ CONFIDEN- │ │
│ │ │ │ INTEGRITY │ │ TIALITY │ │
│ │ Uptime, DR, │ │ Data accuracy │ │ Data │ │
│ │ redundancy │ │ completeness │ │ protection │ │
│ └──────────────┘ └──────────────┘ └──────────────┘ │
│ │
│ ┌──────────────┐ │
│ │ PRIVACY │ Personal data handling │
│ │ │ (overlaps with GDPR) │
│ └──────────────┘ │
│ │
└─────────────────────────────────────────────────────────┘How SOC 2 Maps to Clinical Trial Requirements
| Trust Criterion | Clinical Trial Relevance | EDC Controls |
|---|---|---|
| Security | Protect clinical data from unauthorised access | Access controls, encryption, firewalls, monitoring, incident response |
| Availability | EDC must be accessible for data entry during trial conduct | Uptime SLAs, disaster recovery, redundant infrastructure |
| Processing Integrity | Data must be accurate, complete, and processed correctly | Edit checks, audit trails, validation rules, data integrity controls |
| Confidentiality | Trial data is confidential to the sponsor and sites | Encryption at rest and in transit, access restrictions, data classification |
| Privacy | Participant PII must be protected per regulations | GDPR/HIPAA controls, consent management, data subject rights |
For clinical trial technology, all five criteria are relevant. A vendor that only pursues the Security criterion is missing the complete picture.
Type I vs Type II: The Distinction That Matters
SOC 2 Type I evaluates whether controls are suitably designed at a point in time. It is a snapshot — a photograph of your security posture on one day.
SOC 2 Type II evaluates whether controls operated effectively over a period of time (minimum 6 months). It is a video — evidence that your controls worked consistently, not just on audit day.
┌────────────────────────────────────────────────────┐
│ │
│ Type I Type II │
│ ────── ─────── │
│ "Controls are designed "Controls worked │
│ appropriately" effectively for 6+ months"│
│ │
│ 📸 Snapshot 🎥 Continuous evidence │
│ │
│ Lower assurance Higher assurance │
│ Faster to obtain 6-12 months to complete │
│ Useful as a starting Required by sophisticated │
│ point sponsors and CROs │
│ │
└────────────────────────────────────────────────────┘What to ask your EDC vendor:
- Do they have a SOC 2 Type II report? (Not Type I)
- How recent is the report? (Reports older than 12 months provide diminishing assurance)
- Which Trust Service Criteria does it cover? (Security only, or all five?)
- Is the report prepared by a reputable CPA firm?
- Can they share the report under NDA?
What Auditors Actually Test
A SOC 2 Type II audit is not a checklist. Auditors test operating effectiveness through evidence sampling. Here is what they examine in an EDC context:
Access Controls
- User provisioning and deprovisioning procedures
- Evidence that terminated users are removed promptly
- Multi-factor authentication enforcement
- Quarterly access reviews
Change Management
- Code review requirements before deployment
- Automated testing in CI/CD pipelines
- Change approval workflows
- Rollback procedures
Incident Response
- Documented incident response plan
- Evidence of incident response drills
- Breach notification timelines
- Root cause analysis for past incidents
Monitoring and Logging
- Continuous monitoring of infrastructure and application
- Log retention and review procedures
- Alert configuration and escalation
- Anomaly detection
Encryption and Data Protection
- Encryption standards for data at rest and in transit
- Key management procedures
- Backup encryption and integrity verification
- Data classification and handling procedures
The Continuous Compliance Approach
Traditional SOC 2 preparation involves a scramble before audit season — gathering evidence, documenting processes, testing controls. This approach is fragile and expensive.
Modern technology companies embed SOC 2 controls into their development and operations processes, so evidence is generated continuously:
- Automated tests verify security controls on every code change
- Infrastructure-as-code ensures environments are consistent and auditable
- CI/CD pipelines enforce code review, testing, and approval requirements
- Monitoring and alerting run continuously, not during audit windows
- Access reviews are automated, not manual quarterly exercises
This continuous approach means the system is always audit-ready — not just during the audit period.
Evaluating Your EDC Vendor’s Security Posture
Even if your vendor does not yet have a SOC 2 Type II report, you can assess their readiness by asking these questions:
- Do you have automated compliance tests in your CI/CD pipeline?
- How do you manage access to production data?
- What is your incident response plan, and when was it last tested?
- Do you perform regular penetration testing?
- How do you handle vulnerability management and patching?
- What is your data backup and disaster recovery strategy?
- Can you provide a SOC 2 readiness assessment or bridge letter?
Your Trial Data Deserves Enterprise-Grade Security — Even If Your Budget Is Not Enterprise
Let us be direct: if your EDC vendor cannot answer basic questions about their security controls, you are running clinical trials on a platform you cannot defend to a regulator.
Sponsors are starting to require SOC 2 Type II reports from every vendor in the trial technology chain. CROs are adding it to their vendor qualification checklists. It is no longer a “nice to have” — it is becoming table stakes.
PharmaTrialsCortex is architected for SOC 2 from the ground up:
- Automated compliance tests run on every deployment — audit trail immutability, RBAC enforcement, encryption verification, session controls
- Infrastructure-as-code with full change management and audit logging
- Continuous monitoring with alerting on anomalous access patterns
- Penetration testing performed by independent security firms
- SOC 2 Type II certification is actively in progress with controls already operating
We are not asking you to take our word for it. We are asking you to schedule a security walkthrough and see the controls yourself. Bring your information security team. Bring your vendor qualification checklist. We will show you everything.
Because when a regulator asks how you protect participant data, “we trust our vendor” is not an answer. Evidence is.
Request a compliance demo — we will walk through every SOC 2 control with your team.
For questions about PharmaTrialsCortex’s SOC 2 posture or to request our security documentation, contact security@pharmatrialscortex.com.